Source:http://linkedlifedata.com/resource/pubmed/id/11319334
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-4-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0192-0790
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
463-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11319334-Amylases,
pubmed-meshheading:11319334-Carcinoma, Hepatocellular,
pubmed-meshheading:11319334-Embolization, Therapeutic,
pubmed-meshheading:11319334-Fatal Outcome,
pubmed-meshheading:11319334-Humans,
pubmed-meshheading:11319334-Isoenzymes,
pubmed-meshheading:11319334-Liver Neoplasms,
pubmed-meshheading:11319334-Male,
pubmed-meshheading:11319334-Middle Aged
|
pubmed:articleTitle |
Hyperamylasemia associated with hepatocellular carcinoma.
|
pubmed:publicationType |
Letter,
Case Reports
|